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Promyelocytic leukemia protein (PML) bodies are nuclear sites for both input viral genome deposition and immediate-early
(IE) gene transcription during infection with certain human DNA viruses, such as human cytomegalovirus (HCMV), herpes
simplex virus type 1, and adenovirus. In this study, we showed that the K8 (K-bZIP) protein, an early protein encoded by the
human herpesvirus 8 (HHV-8), colocalized with the PML bodies in HHV-8-infected primary effusion lymphoma cells.
Cotransfection of two plasmids expressing the K8 protein and green-fluorescence protein (GFP)-PML fusion protein into
293T cells revealed that the K8 protein colocalized with PML in cells with high PML expression. Overexpression of the K8
protein in Chinese hamster ovary (CHO) cells with stable GFP-PML expression did not induce the dispersion of the PML
bodies, unlike the IE1 protein of HCMV. Transfection of a truncated K8 gene revealed that the leucine zipper domain of the
K8 protein was required for the colocalization with PML. We also demonstrated that the K8 protein bound to p53 in vivo and
in vitro, and that high expression of the K8 protein caused the accumulation of p53 to the PML bodies in CHO cells,
suggesting that the K8 protein functions in the recruitment of p53 to the PML bodies. These data suggest that the K8 protein
may be associated with the functional modulation of p53 in the nucleus during the lytic phase of HHV-8. © 2001 Academic Press
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aINTRODUCTION
Human herpesvirus 8 (HHV-8; Kaposi’s sarcoma-asso-
ciated herpesvirus, KSHV) is a lymphotropic g-herpesvi-
rus (Russo et al., 1996) involved in the pathogenesis of
Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL;
body-cavity-based lymphoma, BCBL), and a subset of
multicentric Castleman’s diseases (MCDs) (Chang et al.,
1994; Nador et al., 1996; Soulier et al., 1995). A transcript
of HHV-8-encoded K8/K-bZIP was detected in cells of the
BCBL-1 cell line, an HHV-8-positive and Epstein–Barr
virus (EBV)-negative PEL cell line, when BCBL-1 cells
were induced to undergo lytic replication by chemical
treatment with 12-O-tetradecanoylphorbol-13-acetate
(TPA) (Gruffat et al., 1999; Lin et al., 1999). Since the K8
transcript synthesis was blocked by the protein synthe-
sis inhibitor cycloheximide but not by the viral DNA
synthesis inhibitor phosphonoacetate, the K8 transcript
was classified as an early lytic gene (Gruffat et al., 1999;
Lin et al., 1999; Sun et al., 1999). The K8 protein is a
homodimerizing protein consisting of 237 amino acids
with a prototypic basic-leucine zipper (bZIP) domain at
the C-terminal region. The amino acid sequence of the
K8 protein shows significant homology to that of BZLF1,
which plays a key role in the replication and reactivation
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446of EBV. Sequencing and RNase protection analysis re-
vealed that the mRNA transcript (Type I) encoded by K8
gene is 1.35 kb long and also identified two splicing
variants (Type II and Type III), which encode proteins
having the N-terminal portion of the K8 protein but lack-
ing the C-terminal bZIP domain (Lin et al., 1999). The
C-terminal region encompassing the bZIP domain is re-
quired for homodimer formation of the full-length K8
protein (Lin et al., 1999).
The promyelocytic leukemia protein (PML) bodies,
also known as nuclear domain 10 (ND10), PML onco-
genic domains (PODs), Kr bodies, and PML nuclear bod-
ies, were identified as 10–20 spherical structures with a
size of 0.3–0.5 mm in the nuclei of most mammalian cells
Maul, 1998). The PML bodies are formed by multiprotein
omplexes, comprised of PML, Sp100, NDP55, and Daxx
roteins (Ishov et al., 1999). PML was originally identified
s a fusion partner of retinoic acid receptor a (RARa) in
the t(15;17) translocation of acute promyelocytic leuke-
mia cells (Kakizuka et al., 1991). Later, it was shown that
PML is a tumor-suppressor protein (Mu et al., 1994). A
RING finger domain of PML appears to be essential for
the formation of the PML bodies (Le et al., 1996). Al-
though the function of the PML bodies is unknown, they
have been considered as transcriptional and/or accumu-
lative sites for nuclear proteins involved in a nuclear
defense mechanism (Maul, 1998).
Infection with DNA viruses, such as herpes simplex
virus (HSV), human cytomegalovirus (HCMV), and ade-
novirus, has a marked effect on the PML bodies. In
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447HHV-8 K8 COLOCALIZES WITH PML AND BINDS TO p53HSV-1 infection, the viral regulatory protein Vmw-110/
ICP0 (HSV-infected cell protein 0), which is also a mem-
ber of the RING finger protein family, transiently colocal-
izes with PML in the PML bodies and then causes the
dispersion of the PML bodies within 2 h of infection
(Maul et al., 1993). E4ORF3 of adenovirus type 5 (Ad5)
and the large tumor antigen of simian virus 40 (SV40) are
distributed adjacent to the PML bodies in transfected
cells (Ishov and Maul, 1996). HCMV infection also
causes the dispersion of the PML bodies mainly through
the function of the immediate-early (IE) 1 protein of
HCMV (Ahn et al., 1998; Ahn and Hayward, 1997). Trans-
fection experiments showed that the IE1 protein colocal-
ized transiently with PML, and, subsequently, both IE1
and PML were diffusely distributed in the nucleus (Ishov
et al., 1997; Korioth et al., 1996). These DNA viruses use
the PML bodies as the initial sites of transcription. For
example, transcripts of HCMV accumulate around the
IE2 protein in the PML bodies after their dispersion due
to the activity of IE1 (Ahn et al., 1999; Ishov et al., 1997).
For g-herpesviruses, the EBV-encoded nuclear antigen 5
(EBNA-5) also accumulates in the PML bodies of EBV-
infected B cells and cells of EBV-transformed lympho-
blast cell lines (LCL) (Szekely et al., 1996). Thus, many
viral regulatory proteins are associated with the PML
bodies, but the interaction and disruption or reorganiza-
tion of the PML bodies occur in different ways depending
on each virus. Recently, it was demonstrated that K8
protein colocalized with the PML bodies in transfected
cells and at early stages of lytic infection and was also
found to accumulate in functional viral replication center,
suggesting the association with HHV-8 replication (Wu et
al., 2001).
It was shown that high expression levels of PML
induced p53-dependent premature senescence, sug-
gesting that p53 plays an important role in the function of
the PML bodies (Ferbeyre et al., 2000; Guo et al., 2000;
earson et al., 2000). Moreover, Park et al. (2000) re-
ealed that the K8 protein interacted with p53 in vivo and
n vitro and repressed its transcriptional activity. In this
tudy, we showed that the colocalization of the K8 protein
ith the PML bodies required the leucine zipper domain
f the K8 protein by using double- and triple-label immu-
ofluorescence assays (IFA) in combination with confo-
al microscopy. In addition, we also demonstrated the
ssociation of the K8 protein with p53, suggesting that
he K8 protein has the function for recruiting p53 to the
ML bodies possibly through a direct interaction with
53.
RESULTS
he K8 protein colocalizes with PML in PEL cells
Previously, we demonstrated that the K8 protein was
xpressed in the nucleus of HHV-8-infected PEL cells
ith a dot-like staining pattern (Katano et al., 2000),hich we considered to be similar to that of PML re-
orted previously. In addition, we found that PML was
ighly expressed in cells of HHV-8-infected PEL cell
ines, such as TY-1 (Fig. 1), BCBL-1, and KS-1 (data not
hown). To determine whether the distribution patterns
f the K8 protein and PML are identical, IFA was per-
ormed by using TPA-stimulated (20 ng/ml, 48 h) and
onstimulated cells of three HHV-8-infected PEL cell
ines, TY-1, BCBL-1, and KS-1. Figure 1 clearly shows that
he K8 protein and PML colocalize in TPA-stimulated TY-1
ells with a dot-like staining pattern (Figs. 1A–1C, 1J–
M). Colocalization of the K8 protein and PML was fur-
her confirmed by section analysis using confocal mi-
roscopy, since the overlapping of the K8 protein and
ML was observed in every section (Fig. 1E). A small
umber (less than 1%) of nonstimulated TY-1 cells ex-
ress the K8 protein spontaneously, and this colocaliza-
ion was also observed in the nuclei of such cells (Fig.
D). Similar results were also obtained for BCBL-1 and
S-1 cells (data not shown). Although we investigated
ther proteins encoded by HHV-8, including immediate-
arly (open reading frame (ORF) 50), early or late (K2,
RF26, K8.1, K10, K11, ORF59, and ORF65), and latent
ORF73) proteins, none of these proteins colocalized with
ML (data not shown) (Katano et al., 2000, 2001; Szekely
t al., 1999). These data indicate that only the K8 protein
pecifically colocalizes with PML in PEL cells among
HV-8-encoded proteins examined.
eat-shock treatment dissociates the K8 protein from
he PML bodies
Stress such as heat-shock is known to alter the func-
ion and localization of the PML body-associated pro-
eins (Maul, 1998; Szekely et al., 1996). To investigate the
effects of heat-shock stress on the localization of the K8
protein, we carried out heat-shock experiments on TPA-
stimulated TY-1 cells (Szekely et al., 1996). The IFA
showed that the PML bodies remained in the nucleus,
exhibiting a dot-like staining pattern, but the K8 protein
was diffusely distributed in the nucleoplasm following
heat-shock treatment (Figs. 1F–1I), whereas the K8 pro-
tein and PML were colocalized as a dot-like staining
pattern before heat-shock treatment (Figs. 1J–1M). This
indicated that a brief heat-shock treatment led to the
complete dissociation of the K8 protein from the PML
bodies like other PML-associated viral proteins, such as
IE1 of HCMV and EBNA5 of EBV. This phenomenon was
also found to occur in BCBL-1 and KS-1 cells (data not
shown).
Localization of the K8 protein and PML in transfected
293T cells
To confirm the colocalization of PML and the K8 pro-
tein, we performed the transfection experiment of
pHis-K8 into 293T cells. IFA revealed that the K8 protein
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448 KATANO ET AL.distributed as a diffuse staining pattern in the nucleus
near the nuclear membrane and exhibited no dot-like
staining pattern, whereas the 293T cells expressed en-
dogenous PML weakly in the nucleus as a dot-like stain-
ing pattern (Figs. 2A–2C). Careful observations revealed
that the K8 protein and PML colocalized at some PML
bodies as a dot-like staining pattern in a small portion
(,2%) of transfected cells; however, the K8 protein did
not colocalize with the PML bodies in most of the cells.
We thought that this discrepancy between PEL cells and
the K8-transfected 293T cells was due to the expression
level of PML, because PML was usually expressed
highly in HHV-8-infected PEL cells, but not highly in 293T
cells. Then, we carried out cotransfection of pHis-K8 and
pEGFP-PML into 293T cells. Overexpression of GFP-PML
in 293T cells resulted in a dot-like staining of GFP in the
nucleus (the upper-right and lower cells in Figs. 2D–2F).
Since the Sp100 and Daxx proteins colocalized with the
stains of GFP-PML (data not shown), we thought that the
GFP-PML was expressed in the PML bodies of the trans-
fected cells. Figures 2D–2F demonstrate that the K8
FIG. 1. Colocalization of the K8 protein and PML in TPA-stimulated
PA-stimulated TY-1 cells. Superimposing the two colors (C, merge) res
n these figures, and both cells express PML in the nucleus. The K8 p
f the K8 protein and PML in nonstimulated TY-1. The K8 protein
ounterstaining. Arrowheads indicate the colocalization (yellow sign
verlapping of the K8 protein (red) and PML (green) is represented by
istances from the bottom (mm). (F–I) A 30-min heat-shock treatment d
overlap is shown in (I). (J–M) TPA-stimulated TY-1 cells before the heaTY-1 cells. (A–C) The K8 protein (A, red) colocalizes with PML (B, green) in
ults in a yellow signal where the two proteins colocalize. Two cells are seen
rotein is expressed in the left cell, but not in the right cell. (D) Colocalization
is expressed spontaneously in the left cell. Blue color indicates nuclear
als). (E) Ten-micrometer-thick section images of TPA-stimulated TY-1 cells.
yellow color. Numeric characters on the upper right of each image indicateprotein colocalizes with GFP-PML only in 293T cells with
high expression levels of GFP-PML (the lower cell inFIG. 2. Localization of the K8 protein and PML in transfectants. (A–C)
293T cells transfected with pHis-K8. The K8 protein (red) is expressed
with a diffuse staining pattern, whereas expression of endogenous
PML (green) is represented by a dot-like staining pattern. Most of the
PML bodies do not colocalize with the K8 protein. The lower cell is
untransfected. (D–F) 293T cells cotransfected with pHis-K8 and pEGFP-
PML. In the lower cell expressing both the K8 protein (anti-K8 antibody,
Alexa Fluor 568-labeled) and GFP-PML (GFP-labeled), the two proteins
colocalize. The upper right cell expresses only GFP-PML, and the
upper left cell, only the K8 protein.
1
p
f
f
G
449HHV-8 K8 COLOCALIZES WITH PML AND BINDS TO p53Figs. 2D–2F). This colocalization of the K8 protein and
GFP-PML was observed in almost all cells expressing
both the K8 protein and GFP-PML. The K8 protein exhib-
ited a diffuse staining pattern in GFP-PML-untransfected
cells (the upper-left cell in Figs. 2D–2F). These data
indicate that high expression level of PML was required
for colocalization of the K8 protein and PML.
The K8 protein does not have the function for
dispersing the PML bodies
Since the dispersion of the PML bodies is observed
within 4 h of HSV or HCMV infection, dispersion is
considered to be crucial for the replication of these
viruses (Maul, 1998). It was shown that IE1 of HCMV had
the function for dispersing the PML bodies (Ishov et al.,
997; Korioth et al., 1996). Figure 2 suggests that the K8
rotein does not have such a function, because no dif-
use staining pattern of GFP-PML was found in cotrans-
ected 293T cells expressing both the K8 protein and
FP-PML. To confirm it, we transfected pHis-K8 or pHis-
HCMV-IE1 into Chinese hamster overy (CHO) cells stably
expressing GFP-PML (CHO/GFP-PML). Although a large
portion (about 50%) of pHis-HCMV-IE1-transfected CHO/
GFP-PML exhibited a diffuse pattern of GFP-PML stain-
ing (Figs. 3D–3F), no diffuse staining pattern of GFP-PML
was found in pHis-K8-transfected CHO/GFP-PML (Figs.
3A–3C and the upper figures in Fig. 4C). The K8 protein
and GFP-PML were colocalized as a dot-like staining
FIG. 3. The K8 protein has no function for dispersing the PML bodies.
(A–C) Transfection of pHis-K8 to stably-transfected CHO cells express-
ing GFP-PML (CHO/GFP-PML). Cell expressing both the K8 protein and
GFP-PML shows a dot-like pattern of PML staining (the upper cell). The
lower cell expresses only GFP-PML. (D–F) A diffuse staining pattern is
observed in about 50% of HCMV-IE1-transfected CHO/GFP-PML (the
lower cell). The IE1 protein and GFP-PML colocalize in a dot-like
staining pattern in the upper cell.pattern in a large part of CHO/GFP-PML expressing the
K8 protein (the upper figures in Fig. 4C); however, somecells (1%) expressed the K8 protein as diffuse nuclear
staining, which was probably by overexpression (the
upper cell in Figs. 3A–3C). In such cells expressing the
K8 protein diffusely, no dispersion of GFP-PML staining
was found. In addition, we found that the K8 protein and
PML colocalized with a small ubiquitin-modifier 1
(SUMO-1) protein with a dot-like staining pattern in TPA-
stimulated and nonstimulated TY-1 cells (data not
shown), suggesting that the SUMO-1 modification is not
abrogated in the PML bodies of the cells of PEL cell lines
by HHV-8 infection (Muller and Dejean, 1999). Therefore,
we concluded that the K8 protein had no function for
dispersing the PML bodies unlike other PML-associated
viral proteins, such as IE1 of HCMV and ICP0 of HSV-1.
Leucine zipper domain of the K8 protein is required
for colocalization of the K8 protein and PML
The K8 protein has a leucine zipper domain in its
C-terminal, which is thought to be its functional domain.
To identify the functional domain responsible for colocal-
ization with PML, the transfection into CHO/GFP-PML
FIG. 4. The leucine zipper domain of K8 is required for the colocal-
ization of the K8 protein and PML. (A) Construction of K8-expressing
plasmids. See text for further explanation. (B) Western blot for confir-
mation of the expression of Type I (full-length, His-K8) and Type III
(truncated K8, His-K8D) K8 proteins using the pcDNA4/HisMaxA vector.
The anti-K8 polyclonal antibody reacts with His- and Xpress-tagged K8
proteins in lysates of the transfectant (His-K8, 40 kDa; His-K8D, 34 kDa)
and TPA-stimulated TY-1 cells (a wild-type of K8 [K8 (wt)], 35 kDa), but
not with those of the mock (untransfected) and vector. (C) In pHis-K8-
transfected CHO/GFP-PML cells (upper figures), the K8 protein colo-
calized with GFP-PML in a dot-like staining pattern, whereas the K8D
protein is expressed in a diffuse staining pattern and does not colo-
calize with GFP-PML in pHis-K8D-transfected CHO/GFP-PML cells
(lower figures).
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450 KATANO ET AL.was performed by using pHis-K8 (full-length, Type I) or
pHis-K8D (Type III) that expressed the K8 protein with
and without the leucine zipper domain, respectively.
Western blot analysis revealed that pHis-K8 and pHis-
K8D transiently expressed Type I (His-K8) and Type III
(His-K8D) K8 proteins with histidine- and Xpress-tag in
293T cells, respectively (Figs. 4A and 4B). The IFA using
the anti-K8 antibody showed that the K8 protein colocal-
ized with PML observed as a dot-like staining pattern in
the nucleus of pHis-K8-transfected CHO/GFP-PML cells,
whereas the K8D protein was expressed in a diffuse
staining pattern and did not colocalize with PML in pHis-
K8D-transfected CHO/GFP-PML cells (Fig. 4C). These
data clearly indicated that the leucine zipper domain of
K8 protein is required for the colocalization of the K8
protein and PML.
The K8 protein binds to p53 in vivo and in vitro and
colocalizes with p53 in the PML bodies
It is known that p53 accumulates into the PML bodies
under the condition of high expression levels of PML
(Ferbeyre et al., 2000; Pearson et al., 2000). Recently,
binding of the K8 protein and p53 was demonstrated by
another group using antibodies against tags (FLAG and
HIS) (Park et al., 2000). Their results and the colocaliza-
tion of PML with the K8 protein demonstrated in the
present study suggest the possible functional associa-
tion of the K8 protein and p53 in the PML bodies. First,
we investigated the binding of p53 and the K8 protein in
vivo by using the anti-K8 antibody. Immunoprecipitation
assay revealed that the K8 protein bound to p53 in
TPA-stimulated TY-1 cell lysate (Fig. 5A). IFA revealed
that part of staining of the K8 protein overlapped with that
of p53 in TPA-stimulated TY-1 cells (Fig. 5B). Moreover,
the GST pull-down assay revealed that GST-K8 bound to
p53 prepared by in vitro transcription and translation,
whereas GST-K8D did not bind to p53 (Fig. 5C). These
data confirmed the results of the direct binding of the K8
protein and p53 reported by another group (Park et al.,
2000). Figure 5C also suggests that p53 binds to the
leucine zipper domain of the K8 protein in vitro. In addi-
tion, we demonstrated that p53 was immunoprecipitated
by an anti-K8 antibody in the lysate of pHis-K8-trans-
fected 293T cells, but not in the lysate of pHis-K8D- and
pHis (vector)-transfected 293T cells (Fig. 5D), suggesting
that the leucine zipper domain of the K8 protein is re-
quired for its binding to p53 also in vivo.
Although it is known that the overexpression of PML in
mammalian cells induces the accumulation of p53 into
the PML bodies, p53 does not accumulate into the PML
bodies in the established CHO/GFP-PML cells highly
and stably expressing PML (Fig. 6). On the other hand,
p53 colocalized with the K8 protein in some TY-1 cells
(Fig. 5B). Then, we investigated whether the K8 protein
altered the localization of p53. As shown in the left
d
tfigures of Fig. 6, p53 accumulated around the PML bod-
ies in the CHO/GFP-PML cells transfected with pHis-K8,
whereas p53 exhibited a diffuse staining pattern in the
nucleus of untransfected cells (Fig. 6, left). We also
showed that p53 did not accumulate to the PML bodies
in the CHO/GFP-PML cells expressing the K8D protein
(Fig. 6, right).
DISCUSSION
In the present study, we found that the K8 protein
encoded by HHV-8 colocalized with the PML bodies in
HHV-8-infected cells of PEL cell lines, but did not dis-
perse the PML bodies. In addition, our results suggest
that the K8 protein binds to p53 and has the function for
recruiting p53 to the PML bodies.
Recently, colocalization of the K8 protein with PML
was already reported by another group (Wu et al., 2001).
In the present study, we confirmed it and also identified
the fuctional domain for the colocalization, which was
the leucine zipper domain of the K8 protein. With respect
to the colocalization with the PML bodies, the character-
istics of the K8 protein are similar to those of EBNA-5 of
EBV. EBNA-5 accumulates in the PML bodies in EBV-
infected cells, and heat-shock treatment results in the
dissociation of EBNA-5 from the PML bodies (Szekely et
al., 1996). Moreover, EBNA-5 did not function to disperse
the PML bodies (Szekely et al., 1996). These character-
istics of EBNA-5 are obviously different from those of the
PML-body-associated proteins encoded by a- or b-her-
esviruses, such as ICP0 of HSV or IE1 of CMV, suggest-
ng that these characteristics may be specific to g-her-
esviruses. It is unknown whether other HHV-8-encoded
roteins colocalize with PML. Previous reports revealed
hat all viral proteins dispersing the PML bodies were
mmediate-early proteins. Our results showed that the
RF50 protein, an immediate-early protein encoded by
HV-8, was found in the nuclei of TPA-stimulated TY-1
ith a diffuse staining pattern, and part of that staining
ppeared to overlap weakly with PML (Katano et al.,
001), suggesting that the association of the ORF50 pro-
ein with the PML bodies is not as strong as that of the
8 protein. Another immediate-early protein, the K5 pro-
ein, was shown to be localized in the cytoplasm (Haque
t al., 2000). Thus, the immediate-early proteins of HHV-8
o not colocalize specifically with PML, and no PML-
ody-associated protein was found among HHV-8-en-
oded proteins examined so far.
Previous reports revealed that all viral proteins dis-
ersing the PML bodies have a RING finger domain or a
inc-binding motif (Maul, 1998). It was clearly shown in
he transfection experiments of the present study that the
8 protein did not disperse the PML bodies, probably
ecause the K8 gene encoded neither a RING finger
omain nor a zinc-binding motif (Maul, 1998). In addition,
he dispersion of PML was not observed in TPA-stimu-
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451HHV-8 K8 COLOCALIZES WITH PML AND BINDS TO p53lated TY-1 cells, while a large portion of the cells ex-
pressed the K8 protein (Fig. 1). We previously reported
that TPA stimulation induced the expression of the im-
mediate-early (ORF50) and early or late (K2, ORF26, K8.1,
K10, K11, ORF59, and ORF65) proteins in TY-1 cells (Ka-
tano et al., 2000, 2001), and also confirmed in this study
hat these cells expressed these lytic proteins (data not
hown), suggesting that these cells must enter into the
ytic phase. If HHV-8 encodes a protein dispersing the
ML bodies, a diffuse pattern of PML staining should be
bserved in TPA-stimulated TY-1 cells. However, in all
Y-1 cells, PML was expressed and a dot-like staining
attern was observed (Fig. 1), and neither a diffuse
taining pattern nor the dispersion of the PML bodies
as observed after TPA stimulation. This phenomenon is
dentical to that observed in BCBL-1 and KS-1 cells (data
ot shown). Therefore, we speculate that HHV-8 does not
ncode any proteins that function to disperse the PML
odies.
While the EBNA-5 gene is a latency-associated nu-
lear gene (Allday et al., 1989), the K8 gene is an early
lytic gene. The K8 expression occurred slightly after the
expression of ORF50 (Sun et al., 1999), although the
ORF50 and K5 genes were identified as HHV-8-encoded
immediate-early genes (Haque et al., 2000; Lukac et al.,
999; Zhu et al., 1999). It is unknown why an early protein
uch as the K8 protein colocalizes with the PML bodies,
ut we speculate that the K8 protein uses the PML
odies as accumulative sites, and that it is required to
rogress to the next step of the cascade expression of
ther viral proteins. In KS and PEL, almost all tumor cells
an be infected with HHV-8 in the latent phase, and a
ery small population of the cells, in the lytic phase
Katano et al., 1999c, 2000; Parravicini et al., 2000). The
esult of the HHV-8 infection experiment revealed that
HV-8 entered into the latent phase after infection,
hereas a- or b-herpesviruses entered into the lytic
hase (Moses et al., 1999). Thus, the latent phase is
predominant in HHV-8 infection, and it may be important
in the pathogenesis of HHV-8-associated diseases to
maintain the latent infection of HHV-8. Considering that
the dispersion of the PML bodies is crucial for the rep-
lication of HSV, HCMV, and SV40, we speculate that no
dispersion of the PML bodies is related to the mainte-
nance of HHV-8 latency, as well as that of EBV latency.
Further analyses, however, are required to clarify this
hypothesis.
We also found that PML was highly expressed in
HHV-8-infected cells (TY-1, BCBL-1, and KS-1 cells) and
EBV-infected cells (Raji, Namalwa, and LCL), compared
with that in viral-free B cell lines (Ramos and BJAB) (Fig.
1 and data not shown), suggesting that viral infection
induces the expression of PML in B cells. Recently, it was
demonstrated that high expression levels of PML in the
mammalian cells induced p53-dependent senescence
(Ferbeyre et al., 2000; Guo et al., 2000; Pearson et al.,2000). According to these results, p53 is colocalized with
PML in PML-overexpressed cells, and overexpressed
PML forms a p53-PML-CBP/p300 complex, regulates p53
acetylation, and causes premature senescence (Pearson
et al., 2000). Our results indicate that the K8 protein binds
to p53 and colocalizes with p53 in the PML bodies. In
addition, the transfection experiment revealed that p53
was recruited to the PML bodies in K8-transfected CHO/
GFP-PML cells, but not in K8D-transfected CHO/GFP-
PML cells (Fig. 6), suggesting that the K8 protein with the
leucine zipper domain has the function for recruiting p53
to the PML bodies. It is known that p53 is sequestered in
viral replication centers in the nuclei of cells infected
with HCMV (Fortunato and Spector, 1998). However,
there is no report describing viral proteins with a function
for recruiting p53 to the PML bodies thus far. Other
important information about p53 and the K8 protein is
that the K8 protein represses the transcriptional activity
of p53 (Park et al., 2000). It is still unknown whether p53
inhibition by the K8 protein is associated with the colo-
calization of the K8 protein and p53 in the PML bodies.
Further studies are required to clarify the roles of p53
and the K8 protein in the PML bodies.
MATERIALS AND METHODS
Cell culture
TY-1 is an HHV-8-positive and EBV-negative lymphoma
cell line established from a PEL case with acquired
immunodeficiency syndrome (AIDS) (Katano et al.,
1999a). BCBL-1 and KS-1 were also used as HHV-8-
positive and EBV-negative cell lines (Renne et al., 1996;
Said et al., 1996). For stimulation of viral genes, TY-1,
BCBL-1, and KS-1 cells were grown in RPMI medium
supplemented with 10% fetal bovine serum (FBS) and 20
ng/ml TPA for 48 h. 293T and CHO cells were cultured in
Dulbecco’s modified Eagle’s medium supplemented with
10% FBS.
Antibodies and immunofluorescence assay
Cells of the PEL cell lines spotted on slides were fixed
in acetone for 10 min, and were incubated with both
mouse anti-PML monoclonal antibody (PG-M3; Santa
Cruz Biotechnology, Inc., Santa Cruz, CA) and rabbit
anti-K8 protein polyclonal antibody (Katano et al., 2000)
as primary antibodies. The rabbit anti-K8 polyclonal an-
tibody recognizes the 1–189 amino acids of the K8 pro-
tein (Fig. 4A) (Katano et al., 2000). Fluorescein isothio-
cyanate (FITC)-labeled goat anti-mouse immunoglobulin
(Ig) G (Biosource International, Camarillo, CA) and Texas-
Red-labeled goat anti-rabbit IgG antibodies (Cappel, Or-
ganon Teknika Co., Durham, NC) were then used to-
gether as secondary antibodies. In some samples, nu-
clear counterstaining was performed by using TO-PRO 3
(T-3605; Molecular Probe, Eugene, OR). Imaging was
(Lane
8D-tra
452 KATANO ET AL.performed by using a confocal microscope equipped
with an argon-krypton laser (LSM-MicroSystem; Zeiss,
Germany). Using a triple-label assay, three antibodies
against PML, SUMO-1 (goat polyclonal, sc-6375; Santa
Cruz Biotechnology, Inc.) and K8 proteins were mixed
and applied to acetone-fixed TY-1 cells, and allowed to
react at 37°C for 1 h. After washing with phosphate
buffered saline (PBS), the slides were then incubated
separately with FITC-labeled swine anti-goat IgG (Bio-
FIG. 5. The K8 protein binds to p53 in vivo and in vitro. (A) Immunopr
lysate immunoprecipitated with the anti-K8 polyclonal antibody, but not w
in the lysate of TY-1 (Input). (B) Localization of the K8 protein and p53
In vitro binding assay. GST pull-down assay revealed that p53 was dete
beads coupling with the GST-K8 fusion protein, but not with the GST-K8
of the K8 protein. 293T cells were transfected with pHis-K8, pHis-K8D,
with the anti-K8 polyclonal antibody (Lane 1) or preimmune rabbit serum
lysates of pHis-K8-transfected 293T cells, but not from those of pHis-K
FIG. 6. The K8 protein has the function for recruiting p53 to the PML
in the PML bodies of K8-transfected cells (arrows), whereas p53 shows a di
transfected into CHO/GFP-PML. The accumulation of p53 to the PML bodiessource International), Cy5-labeled goat anti-rabbit IgG
(Chemicon International, Temecula, CA) and Texas Red-
labeled rabbit anti-mouse IgG antibodies (Cappel) at
37°C for 30 min each. In the double- or triple-label assay
of transfectants expressing the K8 or HCMV-IE1 protein
with GFP (green-fluorescence protein)-PML, the rabbit
anti-K8 polyclonal antibody, mouse anti-HCMV-IE mono-
clonal antibody (MAB 810; Chemicon International), rab-
bit anti-Daxx polyclonal antibody (M-112, sc7152; Santa
tion of the lysate of TPA-stimulated TY-1 cells. p53 was detected in the
ti-ORF59 and preimmune rabbit serum. An intense band of p53 is found
stimulated TY-1. The K8 protein and p53 partly colocalize (arrows). (C)
the lysates of in vitro-translated p53 (Input) and glutathione-Sepharose
ST protein. (D) The binding to p53 requires the leucine zipper domain
(vector), respectively. Cell lysates (Lane 3) were immunoprecipitated
2). p53 was immunoprecipitated by the anti-K8 antibody only from the
nsfected 293T cells.
. (Left) pHis-K8 was transfected into CHO/GFP-PML. p53 accumulatedecipita
ith an
in TPA-
cted in
D and G
or pHisbodies
ffuse staining pattern in K8-untransfected cells. (Right) pHis-K8D was
was not found.
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453HHV-8 K8 COLOCALIZES WITH PML AND BINDS TO p53Cruz Biotechnology, Inc.), rabbit anti-Sp100 polyclonal
antibody (AB1380; Chemicon International), and/or
mouse anti-p53 monoclonal antibody (DO-7; DAKO) were
used as primary antibodies. Cy5-labeled goat anti-rabbit
IgG (Chemicon International), Alexa Fluor 568-labeled
goat anti-rabbit IgG antibody (A-11036; Molecular
Probes), and/or Alexa Fluor 568-labeled goat anti-mouse
IgG (A-11031; Molecular Probes) were used as second-
ary antibodies.
Heat-shock experiment
The heat-shock experiment was performed to investi-
gate the change in the localization of the K8 protein as
described previously (Szekely et al., 1996). TPA-stimu-
lated TY-1 cells (20 ng/ml, 48 h) were incubated at 45°C
for 30 min and washed briefly with PBS. Cells were
centrifuged on glass slides in a cytospin centrifuge at
350 rpm for 2 min and fixed in acetone.
Plasmid constructions and transfection
We constructed the pHis-K8 and pHis-K8D plasmids
which express Type I (full-length K8 protein) and Type III
(K8D190–237, which lacks amino acids 190–237 of the
Type I K8 protein) K8 proteins, respectively (Lin et al.,
1999). To construct pHis-K8, the K8 gene was amplified
from the cDNA of TPA-stimulated TY-1 cells by PCR using
the primers 8K08F1 (59-CTC gga tcc CCA GAA TGA AGG
ACA TAC CT-39; lower case indicates a restriction en-
zyme site) and 8K8.1R2 (59-CTC ctc gag CAC TAT GTA
GGG TTT CTT ACG-39), and cloned into the BamHI and
XhoI sites of pcDNA4/HisMaxA vector (pHis; Invitrogen,
Groningen, The Netherlands) (Lin et al., 1999). Primers
8K08F1 and 8K08R1 (59-CTC gaa ttc TAT ACC TGC TGC
AGC TGT CT-39) were used for the amplification of the
K8D gene for the construction of pHis-K8D, and the K8D
gene was cloned into the BamHI and EcoRI sites of
pcDNA4/HisMaxA. The IE1 gene of human cytomegalo-
virus was also amplified by PCR from the cDNA of HCMV
(AD169 strain)-infected HEL cells by using the IE1-F-
BamHI primer (59-CCA gga tcc ATG GAG TCC TCT GCC
AAG AGA-39) and IE1-R-EcoRI primer (59-GCA gaa ttc
TTA CTG GTC AGC CTT GCT TCT-39) and cloned into the
BamHI–EcoRI site of pcDNA4/HisMaxA (Invitrogen)
(Akrigg et al., 1985). The PML gene was amplified by PCR
from cDNA of TY-1 cells by using the forward primer
PML-F-EcoRI (59-TCT gaa ttc ATG GAG CCT GCA CCC
GCC CGA-39) and the reverse primer PML-R-BamHI (59-
GGT gga tcc TCA CCA CAA CGC GTT CCT CTC-39), and
cloned into the EcoRI–BamHI site of the pEGFP-C2 vec-
tor (Clontech Laboratories, Palo Alto, CA) for expression
of the GFP-PML fusion protein (pEGFP-PML) (Kakizuka et
al., 1991). 293T cells were seeded onto four-well slide
chambers, and the subconfluent cells were transfected
with the DNA (1 mg/well) using the Fugene 6 transfectionsystem (Roche Diagnostics, Mannheim, Germany) ac-
cording to the manufacturer’s instructions. The cells
were collected 48 h after transfection. To establish stable
CHO cells expressing GFP-PML (CHO/GFP-PML), CHO
cells were transfected with pEGFP-PML using Fugene 6,
and selected with neomycin, and the single-cell cloning
was performed. Expression of GFP-PML was confirmed
by immunofluorescence microscopy.
Western blot analysis
Cells were washed with PBS and lysed with the sam-
pling buffer consisting of 25 mM Tris–HCl (pH 6.5), 5%
glycerol, 1% sodium dodecyl sulfate (SDS), 1% 2-mercap-
toethanol, and 0.05% bromophenol blue. The cell lysate
in the sampling buffer was subjected to 10% SDS–poly-
acrylamide gel electrophoresis (SDS–PAGE) and electro-
transferred onto membranes (Immobilon, Millipore, Bed-
ford, MA). After blocking with Block Ace (Snowbrand Milk
Products, Tokyo, Japan), the membrane was incubated
with the rabbit anti-K8 polyclonal antibody at a dilution of
1:1000 for 1 h at room temperature. Goat anti-rabbit IgG
conjugated with alkaline phosphatase (Biosource Inter-
national) was used as the secondary antibody. The re-
action product was visualized using 4-nitro blue tetrazo-
lium chloride (NBT) and 5-bromo-4-chloro-3-indolyl-phos-
phate (BCIP) (BCIP/NBT membrane phosphatase
substrate system; Kirkegaard and Perry Laboratory,
Gaithersburg, MD).
Immunoprecipitation
The transfected 293T or TPA-stimulated TY-1 cells (1 3
106) were lysed in 1 ml of the lysis buffer (50 mM Tris–
Cl, pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% sodium
eoxycholate, 0.5% Nonidet P-40, 1 mM phenylmethylsul-
onyl fluoride, 100 units/ml aprotinin, and 0.02% sodium
zide). After absorption of protein G-sepharose (Amer-
ham Pharmacia Biotech, Buckinghamshire, U.K.), equal
mounts of cell lysates were incubated with equal
mounts of a polyclonal antibody against the K8 or
RF59 protein or preimmune-rabbit serum (Katano et al.,
999b, 2000). The proteins separated by SDS–PAGE
ere transferred onto membranes (Immobilon, Millipore,
edford, MA).
n vitro binding assays
To investigate the binding of the K8 protein and p53, a
lutathione S-transferase (GST) pull-down assay was
erformed. The GST-K8 fusion gene was generated by
igation of BamHI–XhoI fragments, including the K8 gene
(full-length) of pHis-K8 to the BamHI–XhoI site of pGEX
5X-2 (Amersham Pharmacia Biotech). The GST-K8D fu-
sion protein was also produced by using the BamHI–
EcoRI fragment of K8D gene. These were then expressed
in Escherichia coli and affinity-purified using glutathione-
Sepharose as described previously (Smith and Johnson,
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454 KATANO ET AL.1988). The purity and concentration of the eluted proteins
were determined by SDS–PAGE and the Bradford assay
(Protein Assay; BioRad, New York, NY), respectively. The
p53 gene was amplified by PCR using primers p53-F-
BamHI (59-CT CGG ATC CAG ACT GCC TTC CGG GTC
ACT-39) and p53-R-EcoRI (59-GAG GAA TTC AGT CTG
AGT CAG GCC CTT C-39) and TA-cloned in the pCRII-
TOPO vector (Invitrogen, Carlsbad, CA) (Harlow et al.,
1985). To increase the product of p53 in in vitro transcrip-
tion/translation, the EcoRV–ApaI fragment of the pCRII-
OPO vector was deleted before transcription. The p53
rotein was generated by in vitro transcription-transla-
tion by using the TNT T7 quick coupled transcription/
translation system (Promega, Madison, WI). Five micro-
grams of the GST-K8 or GST-K8D protein that was puri-
fied with glutathione Sepharose 4B column were
incubated with an equal volume of in vitro-translated p53
protein at 4°C for 1 h, and 10 ml of glutathione-Sepharose
eads was added and incubated for 1 h. The beads were
ashed three times in carbonate buffer containing 100
M NaHCO3 and 300 mM NaCl. Bound proteins were
eluted with an equal volume of 23 sampling buffer,
resolved by SDS–PAGE, and analyzed by Western blot-
ting using an anti-p53 monoclonal antibody (DO-7;
DAKO).
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